Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 16.1B | 17.5B | 19.6B | 16.8B |
| Cost of revenue | 7.0B | 7.6B | 8.4B | 7.6B |
| Gross profit | 9.1B | 9.9B | 11.1B | 9.2B |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | — | — | — | — |
| Other operating expenses | 2.1B | 1.8B | 1.8B | 1.6B |
| Operating income | 2.5B | 10.4B | 17.9B | 13.7B |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | 3.4B | 3.0B | 3.5B | 3.2B |
| Other income expense | — | — | — | — |
| Pretax income | -266.7M | 7.4B | 14.5B | 10.6B |
| Tax provision | 365.3M | 1.7B | 3.3B | 1.8B |
| Net income | -632M | 5.7B | 11.2B | 8.8B |
| Basic EPS | — | 9.4 | 18.7 | 14.8 |
| Diluted EPS | — | 9.3 | 18.4 | 14.6 |
| Basic average shares | — | 598.6M | 597.7M | 596.7M |
| Diluted average shares | — | 609.6M | 607.4M | 604.9M |
| EBITDA | 3.4B | 10.7B | 18.2B | 14.0B |
| Net income from continuing op. | — | — | — | — |
| Minority interests | -16.1M | -14.8M | -17.2M | -16.9M |
| Preferred stock dividends | 0 | 0 | 0 | 0 |